Abstract:
Background: Loss to follow-up from ART-treatment is more common and can result to adverse health
impact. In sub-Saharan Africa, including Ethiopia once patients start ART, more than a quarter patients lost
within three years. There is limited evidence on the incidence of loss to follow up and its predictors among
HIV infected adult patients at antiretroviral therapy in the current study areas.
Objective: To assess incidence and predictors of loss to follow-up among human immunodeficiency virusinfected
adult patients after initiation of antiretroviral therapy, at Hadiya zone public hospitals, southern
Ethiopia from 2014- 2018. Data were collected from March 1-25/ 2019.
Methods: An institution based retrospective cohort study design was undertaken. Based on ART
registration records of HIV infected adult patients were categorized into advanced and not advanced
diseases stages. The data were collected from individual folder and database by using data extraction format
for 255 exposed and 297 unexposed total study population. Four health workers from the ART clinic
collected data. Descriptive statistics were done by using Chi-square test and T-test to compare categorical
and continuous variables between the two groups, respectively. Kaplan-Meier failure curves were used to
estimate the probability of loss to follow up after ART initiation. The Cox proportional hazard model was
used to assess predictors associated with loss to follow up after ART initiation.
Results: The incidence rate of loss to follow up among advanced and not advanced disease of adult HIV
infected patients [11.9 per 100 person-years with 95%CI (9.47-14.99)] and [8.6 per 100 person years with
95% CI (6.37-11.67)] respectively. Baseline CD4 cell count < 200cells/mm3[(AHR=3.4, 95%CI: (1.87,
6.18)], advanced disease at ART initiation[(AHR= 0.33, 95%CI: (0.18, 0.58)], not receiving isoniazid
preventive therapy [(AHR= 2.5, 95%CI: (1.64, 3.94)], fair or poor adherence to medication [(AHR= 2.8,
95%CI: (1.87, 4.34)] and ambulatory or bedridden functional status [(AHR= 2.4, 95% CI : (1.33, 4.18)
were significantly associated with loss to follow up. People with worse status were loss to follow up
Conclusions: The overall incidence rate of loss to follow up among adults was 10.5 per 100 person-years,
which was found to be high incidence rate. The loss to follow up among adult HIV infected patients was
associated with low CD4 cell count, advanced disease stage, not receiving IPT, fair or poor adherence and
ambulatory or bedridden functional status. Therefore, strong interventions is needed to address factors
associated with loss to follow up should be implemented for optimal result in patient care.